AusBiotech

Our Chair Hon @JaalaPulford will be leading our mission to the @MedTechCon in Anaheim, USA – join us for a top level visit program and build international connections! ▶️bit.ly/3rIQKa5

A leader in biotech valuation, Dr @patrik_frei (@VValuation) will deliver an exclusive training workshop, “Biotech-Pharma Product and Company Valuation – an introduction”, as part of #AusBio2023 pre-conference activities in Brisbane. Register today > ausbiotechnc.org/workshops

.@TeamImugene licenses allogeneic CAR-T with a potential registration study in 2024 #AusBioNSW biotechdispatch.com.au/news/imugene-l…

.@ANDHealthAU and Brandon BioCatalyst's CUREator+ delivers funding boost to commercially focused BioMedTech startups biotechdispatch.com.au/news/cureator-…

.@Chimeric reports positive in-vitro data for CHM 0301 next-generation cell platform biotechdispatch.com.au/news/chimeric-…

📣AusBiotech 2023 Millis Orator announced Distinguished Australian scientist Emeritus Professor Ian Frazer AC (@ianhfrazer) will deliver the Millis Oration at the #AusBiotech2023 national conference in Brisbane. Find out more here: ausbiotech.org/news/ausbiotec…

.@CSL reports strong profit growth with record plasma collections biotechdispatch.com.au/news/csl-repor…

A major day for @moderna_tx as the company builds its Australian presence biotechdispatch.com.au/news/a-major-d…

AusBiotech launches world-first ESG Guide for biotech SMEs AusBiotech’s landmark A Practical Guide to ESG for Australian Life Sciences Companies is launched to help SMEs attract investment and navigate environmental, social and governance (#ESG) reporting. ausbiotech.org/news/ausbiotec…

.@Merck_Australia partners to pilot the first DeadlyLabs kit biotechdispatch.com.au/news/merck-par…

.@Clarity_Pharma’s theranostic prostate cancer trial advances to highest dose level biotechdispatch.com.au/news/claritys-…

.@QIMRBerghofer's Australian vaccine breakthrough offers hope against EBV-associated cancers and MS biotechdispatch.com.au/news/australia…

AusBiotech is proud to launch ‘A Practical Guide to ESG for Australian Life Sciences Companies’ (the Guide) as a pragmatic and easy-to-use #ESG tool for biotechs. Thank you to @Innov_Aus for profiling this important industry resource. innovationaus.com/industry-first…

AusBiotech weighs in on Industry Growth Program consultation 📃 AusBiotech urges Federal Government to take biotechnology industry’s unique characteristics into account when designing $392.4 million Industry Growth Program. ausbiotech.org/news/ausbiotec…

.@dimerixltd announces successful completion of second DSMB review of ACTION3 trial biotechdispatch.com.au/news/dimerix-a…

.@PeterMacCC selects BindiMaps to launch Victoria’s first hospital ‘Google Maps for indoors’ biotechdispatch.com.au/news/peter-mac…

.@Immutep receives positive scientific advice from the European Medicines Agency #AusBioNSW biotechdispatch.com.au/news/immutep-r…

New AusBiotech report shows increasing US investment in Australian biotechs 📈 Australia continues to attract significant investment from US investors, with US investment into Australian life science companies totaling US1.43 billion between 2018-2022. shorturl.at/tGL78

AusBiotech responds to research funds consultation, stating process must not overtake purpose behind funds, in response to consultation paper Improving alignment and coordination between the MRFFF and NHMRC’s Medical Research Endowment Account (MREA). ausbiotech.org/news/ausbiotec…

Neuren Pharmaceuticals wins Bioshares Excellence Award 🥇 ASX-listed AusBiotech member Neuren Pharmaceuticals (ASX:NEU) swoops up Blake Award for Excellence after a knock-out year including an FDA approval and key commercial partnerships. ausbiotech.org/news/neuren-ph…